News Articles
Latest articles, insights, and updates from the blog.
Need help or want to reach readers?
Have a correction, provider question, or advertising inquiry? Reach the editorial team.
Europe Weighs Psychedelic Therapy Rules Ahead of Approvals
Norway, Germany, Switzerland, the UK and Estonia are discussed at TAIP Conference 2026 as Europe prepares for psychedelic therapy approvals. What it means for ketamine patients.
Oral Ketamine Therapy Shows Promise in Rare Mutism Case
A Cureus case report describes prolonged remission after oral ketamine-assisted psychotherapy in a patient with recurrent dissociative mutism. Here's what it means.
Viral Ketamine Story Blurs Therapy and Drug Use Lines
A Canberra Times profile about ketamine 'changing everything' for a first-time user raises a key question: was it therapy or recreational use? Here's why that matters.
Missouri's First Ketamine Clinic Plans Its Next Move
Missouri's first standalone ketamine therapy practice is reportedly planning growth. Here's what patients should know before choosing a clinic in 2026.
ARPA-H Ibogaine Workshop Puts Safety at Center
ARPA-H’s ibogaine workshop signals a safety-focused push to study potential treatments for opioid use disorder. What patients should know.
Compass Pathways: Extra COMP360 Dose Extends Relief to 1 Year
Compass Pathways reports 52-week open-label data from its COMP005 trial showing a second COMP360 psilocybin dose extended benefit. Here's what patients should know.
New Study Examines Ketamine and Opioid Receptors
A reported study links ketamine to opioid receptor activation. Here is what the early finding may, and may not, mean for patients.
Considering Ketamine Therapy? How to Stay Safe
Ketamine therapy is growing in popularity for depression and mental health, but safety depends on screening, monitoring, and provider choice.
Veterans, First Responders Discuss Ketamine Therapy
Veterans and first responders in Callahan County, Texas shared their experiences with ketamine-assisted therapy. Here's what patients should know about the evidence and access.
Ketamine and Psychedelics May Alter Brain Immunity
New research reported by Neuroscience News suggests ketamine and psychedelics may alter brain immune signaling linked to depression symptoms.
UT Health San Antonio Adds Ketamine to Amputee Care
UT Health San Antonio's Limb Optimization Program now includes ketamine therapy for amputees. Here's what patients should know about this multidisciplinary approach.
Federal Probe Targets Online Ketamine Sellers
Federal officials are investigating online ketamine sellers, WSJ reports. What this regulatory scrutiny means for patients considering at-home ketamine therapy.
COMP360 Phase 3 Data Confirms Rapid TRD Relief
Six-month data from a second Phase 3 trial of COMP360 psilocybin confirms rapid antidepressant effects for treatment-resistant depression. What patients should know.